Trial Profile
A prospective study to evaluate the efficacy of rivaroxaban in patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- 20 Apr 2016 New trial record
- 11 Apr 2016 Results (n=71) published in the European Journal of Clinical Pharmacology.